Company / Cash per Share
Krystal Biotech, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$17.24
FY2025
5-year range
$6.35 / $17.24
FY2021-FY2025
Trend
+41.1%
vs FY2024
Sector context
#11 of 205
Health Care
What the data says
Among 205 Health Care companies, Krystal Biotech, Inc. is in the top 5% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $2.19 in FY2016 to $17.24 in FY2025.
Based on SEC 10-K filings.
17.24 in FY2025 with a 5-year CAGR of +3.8%. Top quartile in the Health Care sector.
Improved from $13.91 to $17.24 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +39.5%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 205This company $17.24 Sector average $72.93
▼
-76.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 41.1% year-over-year.
- Ranks #11 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.24 | +41.1% |
| FY2024 | $12.21 | -12.2% |
| FY2023 | $13.91 | +119.0% |
| FY2022 | $6.35 | -58.7% |
| FY2021 | $15.37 | +7.7% |
| FY2020 | $14.28 | +21.1% |
| FY2019 | $11.79 | +27.4% |
| FY2018 | $9.25 | +0.0% |
| FY2017 | $9.25 | +322.1% |
| FY2016 | $2.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026